Pharming Group N.V. - ADR

XNAS:PHAR

10.46

+0.02 (+0.19%)

7:46:56 PM EDT: $10.89 +0.43 (+4.11%)

Market Cap (Intraday)	740.33M
Current PE	81.11
Forward PE	45.48
2yr Forward PE	49.81

See more stats

Estimates Current Quarter

Revenue	$103.54 Million
Adjusted EPS	$0.16

See more estimates

10-Day MA	$10.75
50-Day MA	$11.50
200-Day MA	$14.67

See more pivots

Pharming Group N.V. - ADR Stock, XNAS:PHAR

Vondellaan 47, Leiden, Zuid-Holland 2332 AA

Netherlands

Phone: +31.71.524.74.00

Number of Employees:

http://www.pharming.com

Description

Pharming Group NV is a holding company, which engages in the development of pharmaceutical products for the treatment of rare diseases and unmet medical needs. The firm offers RUCONEST, which is a recombinant human C1-esterase inhibitor for the treatment of acute hereditary angioedema. It operates through the following segments: RUCONESTÃ?Â®, JoenjaÃ?Â®, Europe, and Rest of the World. The company was founded on November 11, 1988, and is headquartered in Leiden, the Netherlands.